Cargando…

Real-Life Outcome in Multiple Sclerosis in the Czech Republic

BACKGROUND: Cohort studies and registries provide opportunities to estimate long-term outcome in multiple sclerosis. OBJECTIVES: To describe changes in disability (EDSS), relapse activity, and health care consumption over the period 2008-2015 by combining two Czech cost-of-illness studies with disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobelt, Gisela, Jönsson, Linus, Pavelcova, Miluse, Havrdová, Eva Kubala
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397999/ https://www.ncbi.nlm.nih.gov/pubmed/30911417 http://dx.doi.org/10.1155/2019/7290285

Ejemplares similares

Flow Cytometry Analysis of Blood Large Extracellular Vesicles in Patients with Multiple Sclerosis Experiencing Relapse of the Disease
por: Soukup, Jakub, et al.
Publicado: (2022)

The effect of self-assessed fatigue and subjective cognitive impairment on work capacity: The case of multiple sclerosis
por: Kobelt, Gisela, et al.
Publicado: (2018)

Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study
por: Tichá, Veronika, et al.
Publicado: (2016)

The potential of serum neurofilament as biomarker for multiple sclerosis
por: Bittner, Stefan, et al.
Publicado: (2021)

Multiple Sclerosis and Microbiome
por: Preiningerova, Jana Lizrova, et al.
Publicado: (2022)

Genomics in the Czech Republic
por: Paçes, Václav
Publicado: (2003)

Burden and cost of multiple sclerosis in Brazil
por: Kobelt, Gisela, et al.
Publicado: (2019)

Do eyes with and without optic neuritis in multiple sclerosis age equally?
por: Lizrova Preiningerova, Jana, et al.
Publicado: (2018)

Biofeedback Based Home Balance Training can Improve Balance but Not Gait in People with Multiple Sclerosis
por: Novotna, Klara, et al.
Publicado: (2019)

Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic
por: Gkalpakiotis, Spyridon, et al.
Publicado: (2021)

Czech Republic: Transition
Publicado: (1994)

Czech Republic at CERN
Publicado: (1996)

Hantaviruses in the Czech Republic
por: Pejčoch, Milan, et al.
Publicado: (2003)

Accession of the Czech Republic
Publicado: (1993)

Health in the Czech Republic
por: Drobniewski, Francis
Publicado: (1992)

Psychiatry in the Czech Republic
por: Raboch, Jirí
Publicado: (2006)

Comparison of Outcome Data for Shelter Dogs and Cats in the Czech Republic
por: Vojtkovská, Veronika, et al.
Publicado: (2019)

Effects of Menopause in Women With Multiple Sclerosis: An Evidence-Based Review
por: Bove, Riley, et al.
Publicado: (2021)

Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis
por: Ganapathy Subramanian, Ranjani, et al.
Publicado: (2021)

Mosquitoborne Viruses, Czech Republic, 2002
por: Hubálek, Zdenek, et al.
Publicado: (2005)

Predictors of life satisfaction in elders living at home in the Czech Republic
por: Bužgová, Radka, et al.
Publicado: (2023)

Why so moderate? Understanding millennials’ views on the urban housing affordability crisis in the post-socialist context of the Czech Republic
por: Lux, Martin, et al.
Publicado: (2023)

New insights into the burden and costs of multiple sclerosis in Europe
por: Kobelt, Gisela, et al.
Publicado: (2017)

Accession of the Czech Republic to CERN
Publicado: (1993)

Particle Physics in the Czech Republic
por: Vrba, Vaclav
Publicado: (2007)

Real-world effectiveness and safety of fingolimod in patients with multiple sclerosis in the Czech Republic: results from core and extension parts of the GOLEMS study up to 48 months
por: Tichá, Veronika, et al.
Publicado: (2022)

Cognitive clinico‐radiological paradox in early stages of multiple sclerosis
por: Uher, Tomas, et al.
Publicado: (2017)

Molecular Epidemiology of Hantaviruses in the Czech Republic
por: Zelena, Hana, et al.
Publicado: (2019)

Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosis
por: Phelps, Richard, et al.
Publicado: (2019)

Contributions of the Czech Republic, Hungary, Poland and the Slovak Republic
Publicado: (1994)

Contributions of the Czech Republic, Hungary, Poland and the Slovak Republic
Publicado: (1995)

Diurnal raptors at rescue centres in the Czech Republic: Reasons for admission, outcomes, and length of stay
por: Kadlecova, Gabriela, et al.
Publicado: (2022)

Addendum to document CERN/CC/1968 - Accession of the Czech Republic to CERN - "Particle Physics in the Czech Republic"
Publicado: (1993)

Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease
por: Berger, Thomas, et al.
Publicado: (2020)

Mental health reforms in the Czech Republic
por: Pec, Ondrej
Publicado: (2019)

Czech Republic joins IPPOG as member
por: 'marcelloni, claudia
Publicado: (2018)

Accession of the Czech and Slovak Federal Republic
Publicado: (1991)

Accession of the Czech and Slovak Federal Republic
Publicado: (1991)

Accession of the Czech and Slovak Federal Republic
Publicado: (1991)

Overview of healthcare system in the Czech Republic
por: Kinkorová, Judita, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cn39s67afj5b7gqtbsfab62ef9